FDA grounds BioMarin gene therapy trial for months with demand for tumor risk data
FDA grounds BioMarin gene therapy trial for months with demand [...]
FDA grounds BioMarin gene therapy trial for months with demand [...]
GSK, in close race with Pfizer, slams brakes on phase [...]
‘Early stage’: Majority of biotechs don’t disclose ESG practices, but [...]
After clinical hold, Yumanity to cut 60% of workforce by [...]
Recommended Strategies for Your Next Biomarker-Driven Clinical Trial mwen Thu, [...]
Ex-NIH chief Collins returns as science adviser to Biden weeks [...]
Innovent’s phase 3 hits tee it up to challenge Amgen [...]
NIAID vaccine R&D director who collaborated with Moderna on COVID-19 [...]
Gilead comes back around on Hookipa HIV partnership, signing away [...]
Sage, Biogen score on phase 3 depression trial, but we [...]